ZIO-101-C (Darinaparsin)

DRUG2 trials

Sponsors

Alaunos Therapeutics

Conditions

Advanced CancerAdvanced Solid TumorsLymphomas

Phase 1

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Alaunos TherapeuticsAdvanced Solid Tumors, Lymphomas

Start: 2007-12-31End: 2013-06-30Target: 20Updated: 2012-07-19

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Alaunos TherapeuticsAdvanced Cancer

Start: 2007-08-31End: 2013-06-30Updated: 2012-07-19